Early Clinical Experiences of Esketamine Nasal Spray in the UK in Adults with Treatment-Resistant Major Depressive Disorder: Advisory Panel Recommendations
Allan H Young,1 Mohamed Abdelghani,2 Mario F Juruena,1,3 Viktoriya L Nikolova,1 Ramin Nilforooshan4,5 1Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK; 2Camden and Islington NHS Foundation Trust, London, UK; 3Maudsley Advanced Treatment Service (MATS), South L...
Main Authors: | Young AH, Abdelghani M, Juruena MF, Nikolova VL, Nilforooshan R |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-02-01
|
Series: | Neuropsychiatric Disease and Treatment |
Subjects: | |
Online Access: | https://www.dovepress.com/early-clinical-experiences-of-esketamine-nasal-spray-in-the-uk-in-adul-peer-reviewed-fulltext-article-NDT |
Similar Items
-
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Plus a Newly Initiated Oral Antidepressant in Adult Patients with Treatment-Resistant Depression: A Randomized, Double-Blind, Multicenter, Active-Controlled Study Conducted in China and USA
by: Chen X, et al.
Published: (2023-03-01) -
Overcoming the myths of esketamine administration: different and not difficult
by: Florian Buchmayer, et al.
Published: (2023-11-01) -
Esketamine Nasal Spray: Rapid Relief for TRD and Suicide Prevention—Mechanisms and Pharmacodynamics
by: Song H, et al.
Published: (2024-11-01) -
An integrated precision medicine approach in major depressive disorder: a study protocol to create a new algorithm for the prediction of treatment response
by: Bernhard T. Baune, et al.
Published: (2024-01-01) -
How effective are ketamine or esketamine in treatment-resistant depression?
by: N. Veluri, et al.
Published: (2021-04-01)